These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 25302792

  • 1. RASSF1A promoter hypermethylation is a strong biomarker of poor survival in patients with salivary adenoid cystic carcinoma in a Chinese population.
    Zhang CY, Zhao YX, Xia RH, Han J, Wang BS, Tian Z, Wang LZ, Hu YH, Li J.
    PLoS One; 2014; 9(10):e110159. PubMed ID: 25302792
    [Abstract] [Full Text] [Related]

  • 2. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma.
    Li J, El-Naggar A, Mao L.
    Cancer; 2005 Aug 15; 104(4):771-6. PubMed ID: 15959912
    [Abstract] [Full Text] [Related]

  • 3. Identification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screening.
    Ling S, Rettig EM, Tan M, Chang X, Wang Z, Brait M, Bishop JA, Fertig EJ, Considine M, Wick MJ, Ha PK.
    Int J Oncol; 2016 Jul 15; 49(1):225-34. PubMed ID: 27212063
    [Abstract] [Full Text] [Related]

  • 4. [DNA methylation in salivary adenoid cystic carcinoma cell lines].
    Zhang CY, Zhou XJ, Zhang ZY, Li J.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Mar 15; 42(3):135-9. PubMed ID: 17565817
    [Abstract] [Full Text] [Related]

  • 5. Critical regions and spreading of runt-related transcription factor-3 C-phosphate-G (CpG) island methylation in human salivary gland adenoid cystic carcinoma.
    Ge MH, Chen C, Xu JJ, Ling ZQ.
    Hum Pathol; 2011 Dec 15; 42(12):1862-72. PubMed ID: 21658745
    [Abstract] [Full Text] [Related]

  • 6. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS, Chae Y, Ha YS, Kim IY, Byun SS, Yun SJ, Kim WJ.
    Clin Genitourin Cancer; 2012 Jun 15; 10(2):114-20. PubMed ID: 22382007
    [Abstract] [Full Text] [Related]

  • 7. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.
    Clin Cancer Res; 2008 May 01; 14(9):2664-72. PubMed ID: 18451230
    [Abstract] [Full Text] [Related]

  • 8. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.
    Schwarz S, Müller M, Ettl T, Stockmann P, Zenk J, Agaimy A.
    Int J Clin Exp Pathol; 2011 Apr 01; 4(4):336-48. PubMed ID: 21577319
    [Abstract] [Full Text] [Related]

  • 9. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
    Ouyang DQ, Liang LZ, Ke ZF, Zheng GS, Weng DS, Yang WF, Su YX, Liao GQ.
    Head Neck; 2017 Jun 01; 39(6):1145-1154. PubMed ID: 28230926
    [Abstract] [Full Text] [Related]

  • 10. High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.
    Xia R, Zhou R, Tian Z, Zhang C, Wang L, Hu Y, Han J, Li J.
    Arch Pathol Lab Med; 2013 Dec 01; 137(12):1761-9. PubMed ID: 24283856
    [Abstract] [Full Text] [Related]

  • 11. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
    Zhang CY, Mao L, Li L, Tian Z, Zhou XJ, Zhang ZY, Li J.
    Cancer; 2007 Jul 01; 110(1):87-95. PubMed ID: 17520682
    [Abstract] [Full Text] [Related]

  • 12. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
    Ferrarotto R, Mitani Y, Diao L, Guijarro I, Wang J, Zweidler-McKay P, Bell D, William WN, Glisson BS, Wick MJ, Kapoun AM, Patnaik A, Eckhardt G, Munster P, Faoro L, Dupont J, Lee JJ, Futreal A, El-Naggar AK, Heymach JV.
    J Clin Oncol; 2017 Jan 20; 35(3):352-360. PubMed ID: 27870570
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.
    Sasahira T, Kurihara M, Yamamoto K, Bhawal UK, Kirita T, Kuniyasu H.
    Cancer Sci; 2011 Feb 20; 102(2):492-7. PubMed ID: 21105967
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.
    Šteiner P, Andreasen S, Grossmann P, Hauer L, Vaněček T, Miesbauerová M, Santana T, Kiss K, Slouka D, Skálová A.
    Virchows Arch; 2018 Oct 20; 473(4):471-480. PubMed ID: 29619555
    [Abstract] [Full Text] [Related]

  • 15. [Expression of DNA methyltransferases in salivary adenoid cystic carcinoma and its association with the CpG islands methylation of tumor suppressor genes].
    Tian Z, Zhang ZY, Li L, Li J.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jul 20; 41(7):411-5. PubMed ID: 17067458
    [Abstract] [Full Text] [Related]

  • 16. Unfavorable clinical implications for hypermethylation of RUNX3 in patients with salivary gland adenoid cystic carcinoma.
    Ge MH, Chen C, Xu JJ, Ling ZQ.
    Oncol Rep; 2011 Aug 20; 26(2):349-57. PubMed ID: 21567090
    [Abstract] [Full Text] [Related]

  • 17. Loss of heterozygosity at chromosome 6q23-25 correlates with clinical and histologic parameters in salivary gland adenoid cystic carcinoma.
    Stallmach I, Zenklusen P, Komminoth P, Schmid S, Perren A, Roos M, Jianming Z, Heitz PU, Pfaltz M.
    Virchows Arch; 2002 Jan 20; 440(1):77-84. PubMed ID: 11942580
    [Abstract] [Full Text] [Related]

  • 18. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML, Tao Q, Fu L, Wong KY, Qiu GH, Law FB, Tin PC, Cheung WL, Lee PY, Tang JC, Tsao GS, Lam KY, Law S, Wong J, Srivastava G.
    Int J Oncol; 2006 Mar 20; 28(3):767-73. PubMed ID: 16465383
    [Abstract] [Full Text] [Related]

  • 19. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
    Balgkouranidou I, Matthaios D, Karayiannakis A, Bolanaki H, Michailidis P, Xenidis N, Amarantidis K, Chelis L, Trypsianis G, Chatzaki E, Lianidou ES, Kakolyris S.
    Mutat Res; 2015 Aug 20; 778():46-51. PubMed ID: 26073472
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of MYB promoter methylation in salivary adenoid cystic carcinoma.
    Shao C, Bai W, Junn JC, Uemura M, Hennessey PT, Zaboli D, Sidransky D, Califano JA, Ha PK.
    Oral Oncol; 2011 Apr 20; 47(4):251-5. PubMed ID: 21324728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.